MedTrace Logo

The Effect of L-Carnitine on Wound Healing in Patients With Diabetic Foot Ulcer.

NCT07768228 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2026-08-17

No results posted yet for this study

Summary

Primary outcome: To evaluate the efficacy of L-Carnitine supplementation on length and depth ulcer size

Secondary outcome: To investigate the effect of L-Carnitine supplements on:

1. Vascular endothelial growth factor (VEGF)
2. Inflammatory markers TNF-a (Tumor necrosis factor alpha).
3. Hemoglobin A1C (HbA1c) And Lipid profile (cholesterol, triglycerides, high-density Lipoprotein (HDL) and low-density lipoprotein (LDL)).
4. To assess the type and likelihood of any adverse drug reaction that can be related to L-Carnitine supplementation.
5. QOL (DIABETES 39)

Conditions

  • Diabetic Foot Ulcer
  • Diabetic Foot Ulcer (DFU)

Interventions

DRUG

L- carnitine

oral L-carnitine

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-09-01
Primary Completion
2027-07-01
Completion
2027-08-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07768228 on ClinicalTrials.gov